Krishnan, A., Nooka, A. K., Chari, A., Garfall, A., Martin, T., Nair, S., . . . Usmani, S. (2022). PB2013: TECLISTAMAB COMPARED WITH REAL-WORLD THERAPIES IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA. Wiley.
Chicago Style (17th ed.) CitationKrishnan, A., et al. PB2013: TECLISTAMAB COMPARED WITH REAL-WORLD THERAPIES IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA. Wiley, 2022.
MLA (9th ed.) CitationKrishnan, A., et al. PB2013: TECLISTAMAB COMPARED WITH REAL-WORLD THERAPIES IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA. Wiley, 2022.
Warning: These citations may not always be 100% accurate.